Journal article
Combined moderate dose electron beam radiotherapy and topical chemotherapy for cutaneous t-cell lymphoma
International journal of radiation oncology, biology, physics, v 9(4), pp 475-479
1983
PMID: 6406398
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Between October, 1978 and June, 1979, nine patients with biopsy-proven cutaneous T-Cell lymphoma were treated with combined total-skin electron beam radiation (TSEB) and topical chemotherapy. TSEB was administered using 3.8 MeV electron and dual exposure technique. All patients received skin dose of 400 rad once weekly to a total dose of 2000 to 2400 rad followed by topical chemotherapy with mechlorethamine hydrochloride (HN2)
∗ two to four weeks after completion of radiation. A complete response followed TSEB in seven of nine patients, but a relapse of disease activity has subsequently occurred within the first year for all the patients despite adjunct therapy, except for one patient who remains disease free for more than 21 months. Generalized severe erythema developed during or shortly after completion of radiation in six of nine patients, with blistering at the overlapping treatment fields and body folds in four patients. In addition four patients developed diffuse permanent telangiectasia of skin and one patient developed linear sclerosis, telangiectasis and painful ischemic ulceration on the fingertips two years after completion of electron beam therapy. Most patients had evidence of mild depression of lymphocyte responsiveness to Phytohemagglutinin after TSEB. Our conclusion is that the short-term benefits and convenience of this particular technique do not justify the acute and chronic toxicity encountered.
Metrics
Details
- Title
- Combined moderate dose electron beam radiotherapy and topical chemotherapy for cutaneous t-cell lymphoma
- Creators
- Bizhan Micaily - Department of Radiation Therapy and Nuclear Medicine, Hahnemann University of the Health Sciences, Philadelphia, PA 19102 USAEric C. bonderheid - Temple UniversityLuther W. Brady - Department of Radiation Therapy and Nuclear Medicine, Hahnemann University of the Health Sciences, Philadelphia, PA 19102 USA
- Publication Details
- International journal of radiation oncology, biology, physics, v 9(4), pp 475-479
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:A1983QQ49500006
- Scopus ID
- 2-s2.0-0020624506
- Other Identifier
- 991019183969604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging